CD274 and infection: Our data indicate that blockade of B7-H1 did not have a significant effect on disease onset, but enhanced the chronic course of TMEV-IDD during the autoimmune phase of disease (Figure 8), although mice treated with anti-B7-H1 mAb have similar TMEV viral loads in the brains at day 7 post-infection compared to isotype controls (Figure 9).